Technical Analysis for BNR - Burning Rock Biotech Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Historical BNR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Inside Day | Range Contraction | -2.40% | |
| Hammer Candlestick | Bullish | -3.56% | |
| Pocket Pivot | Bullish Swing Setup | -3.56% | |
| Doji - Bullish? | Reversal | -3.56% | |
| Hot IPO Pullback | Bullish Swing Setup | -1.63% | |
| Multiple of Ten Bearish | Other | -1.63% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Diagnostics & Research
Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
Medicine Cancer Medical Specialties Clinical Medicine Oncology Prostate Cancer Tumor Breast Cancer Infectious Causes Of Cancer Colorectal Cancer Lung Cancer Biopsy Thyroid Cancer Hereditary Cancers
Medicine Cancer Medical Specialties Clinical Medicine Oncology Prostate Cancer Tumor Breast Cancer Infectious Causes Of Cancer Colorectal Cancer Lung Cancer Biopsy Thyroid Cancer Hereditary Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 32.4 |
| 52 Week Low | 22.5 |
| Average Volume | 363,096 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 27.12 |
| 10-Day Moving Average | 26.70 |
| Average True Range | 2.26 |
| ADX | 0.0 |
| +DI | 21.60 |
| -DI | 15.73 |
| Chandelier Exit (Long, 3 ATRs ) | 25.63 |
| Chandelier Exit (Short, 3 ATRs ) | 29.27 |
| Upper Bollinger Band | 31.63 |
| Lower Bollinger Band | 22.61 |
| Percent B (%b) | 0.38 |
| BandWidth | 33.24 |
| MACD Line | -0.39 |
| MACD Signal Line | -0.23 |
| MACD Histogram | -0.1617 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.67 | ||||
| Resistance 3 (R3) | 27.78 | 27.34 | 27.40 | ||
| Resistance 2 (R2) | 27.34 | 26.92 | 27.29 | 27.31 | |
| Resistance 1 (R1) | 26.69 | 26.66 | 27.01 | 26.58 | 27.22 |
| Pivot Point | 26.25 | 26.25 | 26.41 | 26.19 | 26.25 |
| Support 1 (S1) | 25.59 | 25.83 | 25.92 | 25.48 | 24.84 |
| Support 2 (S2) | 25.15 | 25.57 | 25.10 | 24.75 | |
| Support 3 (S3) | 24.50 | 25.15 | 24.66 | ||
| Support 4 (S4) | 24.39 |
